![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication November 26, 2007.
Revised January 23, 2008.
Accepted for publication January 23, 2008.
The human dopamine D2L receptor couples promiscuously to multiple members of the G
i/o subfamily. Despite the high homology of the D2L and D3 receptors, the G protein-coupling specificity of the human D3 receptor is less clearly characterized. The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D2L and D3 receptors. By employing both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual G
i-family G proteins were expressed in an inducible fashion we demonstrated highly selective coupling of the D3 receptor to G
o1. Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D3 receptor when coupled to G
o1 as compared to the D2L receptor. The second aim of this study was to investigate the molecular basis of the above differential G protein-coupling specificity. The importance of a twelve amino acid sequence from the C-terminal end of the third intracellular loop of the D2L receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D3/D2 receptor in which the equivalent region of the D3 receptor was exchanged for this sequence. This chimera displayed D3-like affinity for [3H] spiperone and potency for agonists, but gained D2-like ability to couple to each of G
i1-3 as well as G
o1.
Key words:
G protein coupled receptors, G proteins, antipsychotic drugs, dopamine, functional selectivity, signal transduction